Drugs / autologous adipose-derived regenerative cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03296501 | Oct 2015 → Oct 2020 | amyotrophic lateral sclerosis | Mossakowski Medical Research Centre Polish Academy of Sciences | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous adipose-derived regenerative cells | “Here, we describe a pilot study on transplantation of autologous adipose-derived regenerative cells (ADRC) into the spinal cord of the patients with ALS and monitoring of the...” PMID 30158984 ↗ Aug 2018 |
| Known as | ADRC | “Here, we describe a pilot study on transplantation of autologous adipose-derived regenerative cells (ADRC) into the spinal cord of the patients with ALS and monitoring of the...” PMID 30158984 ↗ Aug 2018 |
| Modality | Cell therapy | “cell therapy” PMID 30158984 ↗ Aug 2018 |
| Route | Other | “an intraspinal injection” NCT03296501 ↗ |